Axplora Aims to Make Pharmaceutical Supply Chains More Stable
Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.
Expert Statement: Girish Malhotra, EPCOT International
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Making Better Use of Spectral and Chromatographic Data in Product and Process Development
Working with spectral and chromatographic data often results in noisy data. The good news is, there is a simple and efficient way to extract the signals from the noise, enabling a deeper and better understanding of processes and products.
PARTEC 2023: Call for Papers
The 2023 edition of PARTEC, the International Congress on Particle Technology, will take place on September 26−28, 2023 in Nuremberg, Germany. As one of the world's major scientific congresses for particle and bulk solids technology, it provides an international forum for R&D in new technologies.
AI Maturity Model for GxP Application
Artificial intelligence (AI) has become one of the supporting pillars for digitalization in many areas of the business world. The pharmaceutical industry and its GxP-regulated areas also want to use AI in a beneficial way, but only a small fraction of companies follows a systematic approach for the digitalization of their operations and validation. However, the assurance of integrity and quality of outputs via computerized system validation is essential for applications in GxP environments.
Sustainability and the Chemicals Industry
The chemicals industry is one of the world’s largest industrial sectors, worth €3,471 billion in 2020. It includes producers of industrial chemicals, polymers, pesticides, food and feed additives, and cosmetics, and is growing rapidly. By some estimates it will reach almost $22,000 billion by 2060.
Halving Chemical Manufacturing Costs
Traditional batch chemistry is too inefficient for a sustainable future. Switching batch processing to continuous processing is inevitable if the world is to reach net zero.
Sustainable Industrial Wastewater Treatment
For decades, Ferrate(VI) has been known as the strongest oxidant in the world for the treatment of (industrial) wastewater.
Investing in Growth Through Innovation
Interview with Marc Doyle, CEO of Arxada, which was created following the carve-out and sale of Lonza Specialty Ingredients to private equity firms Bain Capital and Cinven.
Ensuring API Supply Capacities for Europe and Beyond
Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.
Expert Statement: Jean-Baptiste Guillermin, Axplora
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Expert Statement: Stephen D Drake, Kaneka Americas Holdings
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Expert Statement: Christophe Girard, Siegfried
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Expert Statement: Baburaj Krishnan, Aurigene Pharmaceutical Services
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Expert Statement: Mark Muldowney, Sterling Pharma Solutions
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Expert Statement: Srividya Ramakrishnan, Dr. Reddy’s Laboratories
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Expert Statement: Ulrich Mayerhoeffer, Arxada
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Expert Statement: Shawn Walker, Veranova
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Expert Statement: Kai Rossen, Euroapi
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Circular economy in Europe: building new synergies
The Serbian Elixir Group has made a name for itself as one of the leading producers of mineral fertilizers and phosphoric acid in Eastern Europe.
Modern day solutions for high speed and environmentally friendly disinfection of food and beverage packaging materials
To ensure that food products remain fresh and edible for as long as possible, strict hygienic conditions must be met, not only in terms of product quality but also during the filling and packaging process.
The Japanese Pharma Market
Japan continues to be one of the largest pharmaceutical markets in the world, making up approximately 7% of the global share. Historically, Japan has been viewed as insular compared to other developed markets such as Europe or the US, with foreign companies reporting high barriers to entry.
Overall Equipment Effectiveness (OEE)
The primary goal for any manufacturing or process organization is to produce a profit and return on net asset (RONA) to shareholders and other stakeholders. Safety and environmental performance are secondary goals – not secondary in importance, but no manufacturing plant was ever built with the sole and explicit purpose of being safe and environmentally responsible.
Elixir focuses on modern recycling management, expanded product portfolio and service at Prahovo Chemical Park
With 1,650 employees and an annual turnover of EUR 320 million, the Serbian Elixir Group is one of the leading mineral fertilizer and phosphoric acid producers in Eastern Europe.
Proactive Supplier Risk Mitigation for Manufacturing and Testing Organizations
There is a new urgency in the market for manufacturers and testing organizations to be prepared for rapid, unexpected changes in material resource access, exacerbated by turbulent regional and global events. This focus is in addition to reinforcing routine risk mitigation activities around the raw material supply chain, adding to the relevance and impact of the topic.
AI Makes Drug Discovery Faster
Interview with Joachim Haupt and Florian Kaiser, PharmAI
Nanoparticle Engineering
The value in applying AI in Pharma is in making new and better drugs available faster than would be possible otherwise. By augmenting sparse-data AI with expert knowledge and applying it to the latest nanoparticle engineering techniques, opportunities are created to eliminate the risk associated with new techniques and give therapeutics a second chance to reach the patients who need them.
Challenging the Status Quo
Management pays a lot of attention to new ideas and cutting-edge technologies, but most of their resources are consumed by mature legacy technologies that are often not actively and rigorously managed. A visual matrix can help teams understand which technologies offer the greatest long-term potential for businesses.
The Time Has Come
For many years, fine and specialty chemicals markets were on a robust growth path.
An Innovative Wet Sulfuric Acid Process
In many industrial applications the wet sulfuric acid process is the most important technology for recovery of sulfuric acid and energy from sulfur bearing compounds.
Micro- and Millireactors on the Upswing
At an online roundtable event hosted by CHEManager, a group of industry experts discussed the reasons why microreaction technology (MRT) has not achieved the status for instance in fine chemicals and active ingredients production that one might expect as well as various business and production aspects of the technology.
Expanding Into Oligonucleotides
The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this competitive environment a few years ago and meanwhile has passed certain milestones on its way to become a preferred oligonucleotide manufacturing partner for pharmaceutical companies.
